These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4114505)

  • 1. Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome.
    Brown JJ; Fraser R; Love DR; Ferriss JB; Lever AF; Robertson JI; Wilson A
    Lancet; 1972 Aug; 2(7771):243-7. PubMed ID: 4114505
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases of low-renin hypertension thought to be due to excessive secretion of unknown mineralocorticoid.
    Haruyama K; Yamazaki M; Toki T; Fukuchi S
    Jpn Circ J; 1982 Feb; 46(2):156-61. PubMed ID: 6276583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 4. Deoxycorticosterone and 17-ketosteroids. Elevated levels in adult hypertensive patients.
    Tan SY; Noth RH; Mulrow PJ
    JAMA; 1978 Jul; 240(2):123-6. PubMed ID: 660829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma deoxycorticosterone and aldosterone in essential hypertension.
    Honda M; Nowaczynski W; Messerli FH; Kuchel O; Genest J
    J Steroid Biochem; 1976 Aug; 7():565-9. PubMed ID: 183059
    [No Abstract]   [Full Text] [Related]  

  • 6. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
    Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
    Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma aldosterone in essential hypertension with low renin activity.
    Fukuchi S; Nakajima K; Takenouchi T; Nishisato K
    Jpn Circ J; 1974 Dec; 38(12):1071-7. PubMed ID: 4436936
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
    New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
    J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low renin essential hypertension in a child.
    Leumann EP; Nussberger J; Vetter W
    Helv Paediatr Acta; 1976 Jan; 30(4-5):357-63. PubMed ID: 1245435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's disease: evaluation of mineralocorticoid-induced hypertension.
    Yasuda G; Shionoiri H; Hayashi S; Umemura S; Ikeda Y; Ishii M
    Intern Med; 1993 Oct; 32(10):784-8. PubMed ID: 8012073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.
    Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A
    Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible role of 18-hydroxy-deoxycorticosterone in hypertension.
    Rapp JP; Dahl LK
    Nature; 1972 Jun; 237(5354):338-9. PubMed ID: 4557399
    [No Abstract]   [Full Text] [Related]  

  • 15. A rare cause of hypertension in childhood: Answers.
    Kucuk N; Yavas Abalı Z; Abalı S; Canpolat N; Yesil G; Turan S; Bereket A; Guran T
    Pediatr Nephrol; 2020 Jan; 35(1):79-82. PubMed ID: 31541304
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of cortisol infusion on plasma renin activity, aldosterone levels and 11-deoxycorticosterone levels in humans (author's transl)].
    Sugawara T
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):710-8. PubMed ID: 689214
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension treatable with glucocorticoids: report of a case].
    Montero J; Fardella C; Mosso L
    Rev Med Chil; 1997 Nov; 125(11):1361-5. PubMed ID: 9609059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an unidentified, adrenocorticotrophic hormone-dependent mineralocorticoid maintaining hypertension in young women with hypoaldosteronism.
    Hoefnagels WH; Drayer JI; Hofman JA; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Sci Mol Med Suppl; 1978 Dec; 4():271s-274s. PubMed ID: 282066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.